Skip to content

Opening book details…

About this Medicine article

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer by Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, O. N.; Perez, E. A.; Yardley, D. A.; Chan, S. Y. T.; Zhou, X.; Phan, S.-C.; O'Shaughnessy, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, O. N.; Perez, E. A.; Yardley, D. A.; Chan, S. Y. T.; Zhou, X.; Phan, S.-C.; O'Shaughnessy, J.
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, O. N.; Perez, E. A.; Yardley, D. A.; Chan, S. Y. T.; Zhou, X.; Phan, S.-C.; O'Shaughnessy, J.

Browse all works by Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, O. N.; Perez, E. A.; Yardley, D. A.; Chan, S. Y. T.; Zhou, X.; Phan, S.-C.; O'Shaughnessy, J.